Candida auris: an Emerging Fungal Pathogen
Open accessAbstract
Candida auris has emerged globally as a multidrug-resistant health care-associated fungal pathogen. Recent reports highlight ongoing challenges due to organism misidentification, high rates of antifungal drug resistance, and significant patient mortality. The predilection for transmission within and between health care facilities possibly promoted by virulence factors that facilitate skin colonization and environmental persistence is unique among Candida species. This minireview details the global emergence of C. auris and discusses issues relevant to clinical microbiology laboratories, hospital infection control, and antimicrobial stewardship efforts.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
C. auris isolates have been implicated in nosocomial outbreaks worldwide, with 5 distinct clades classified by region of independent emergence.
“C. auris isolates have been implicated in nosocomial outbreaks worldwide, with 5 distinct clades classified by region of independent emergence.”
The citation lists haven’t been fetched yet
References 46 · Cited by 393
- Authors
- Spivak, E. S., & Hanson, K. E.
- Affiliations
- University of Utah (US)
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2018-02
- Volume
- 56
- Issue
- 2
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC5786713
- OpenAlex
- W2769754674
- Cited by
- 393
- References
- 46
- Citations by year
- 2026: 22 · 2025: 37 · 2024: 54 · 2023: 50 · 2022: 59 · 2021: 55 · 2020: 66 · 2019: 30 · 2018: 18
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Yeasts and Rust Fungi Studies
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Keywords
- Candida auris, emerging fungal pathogens, multidrug resistance, antifungal resistance, nosocomial infections, virulence factors, skin colonization, environmental persistence, hospital infection control, antimicrobial stewardship, clinical microbiology laboratory
- MeSH terms
- Antimicrobial Stewardship, Antifungal Agents, Candida, Candidiasis, Cross Infection, Humans, Skin, Clinical Laboratory Techniques, Drug Resistance, Fungal, Virulence Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
